Farallon Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $107K | Hold |
27,600
| – | – | ﹤0.01% | 123 |
|
|
2025
Q1 | $138K | Hold |
27,600
| – | – | ﹤0.01% | 123 |
|
|
2024
Q4 | $199K | Hold |
27,600
| – | – | ﹤0.01% | 122 |
|
|
2024
Q3 | $169K | Hold |
27,600
| – | – | ﹤0.01% | 141 |
|
|
2024
Q2 | $184K | Sell |
27,600
-442,400
| -94% | -$2.94M | ﹤0.01% | 137 |
|
|
2024
Q1 | $4.78M | Buy |
470,000
+436,000
| +1,282% | +$4.44M | 0.02% | 98 |
|
|
2023
Q4 | $383K | Buy |
+34,000
| New | +$383K | ﹤0.01% | 112 |
|